Navigation Links
Optimer Pharmaceuticals' Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
Date:8/19/2010

elihood that healthcare professionals would use fidaxomicin, if approved, and the awareness of CDI among healthcare professionals. Words such as "believes", "would", "anticipates", "plans", "expects", "may", "intend", "will", and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements represent Optimer's judgment as of the time of this release and should not be regarded as a representation by Optimer that any of its plans will be achieved. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in Optimer's business including, without limitation, risks relating to: the development of alternative treatments for or means of preventing CDI, whether regulatory authorities will review or approve Optimer's applications for marketing approval, the timing of any marketing approvals, Optimer 's ability to enter into a collaboration with respect to fidaxomicin on favorable terms or at all, Optimer's ability to complete its NDA submission in a timely manner, Optimer's ability to commercialize any products for which it receives marketing approval, whether healthcare professionals will prescribe fidaxomicin, if approved, whether fidaxomicin will receive reimbursement coverage from healthcare payors and government agencies and other risks detailed in Optimer's filings with the Securities and Exchange Commission.  Optimer disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.ContactsOptimer Pharmaceuticals, Inc.Christina Donaghy, Corporate Communications ManagerJohn D. Prunty, Chief Financial Officer & VP Finance858-909-0736Canale Communications, Inc.Jason I. Spark, Senior Vice President619-849-6005
'/>"/>
SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
3. Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
4. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
5. Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
6. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
7. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... July 7, 2015  PAREXEL International Corporation (NASDAQ: PRXL ... Fiscal Year 2015 on Wednesday, August 5 th , 2015 ... be available on PAREXEL,s website at www.PAREXEL.com and ... PAREXEL will host a conference call and live webcast at ... to discuss the results.  To access the webcast, visit PAREXEL,s ...
(Date:7/7/2015)... , July 7, 2015 /PRNewswire/ -- Mindray Medical International ... developer, manufacturer and marketer of medical devices worldwide, ... remaining stake in Wuhan Dragonbio Surgical Implant Co., ... Dragonbio is a domestic medical orthopedic-product provider ... surgical products. Prior to today,s announcement, Mindray already ...
(Date:7/7/2015)... 2015 Oasmia Pharmaceutical AB, ... within human and veterinary oncology, today announced that ... the United States , designed to ... animal therapeutic.      (Logo: http://photos.prnewswire.com/prnh/20150420/740096) , ... , Paccal Vet-CA1 was previously distributed ...
Breaking Medicine Technology:PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2015 Earnings Release And Conference Call 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 3Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 4Oasmia Pharmaceutical Launches US Brand and Sales Platform 2
... CMR Institute , the leading provider of non-brand ... of two new e-modules to help representatives better prepare for ... The Affordable Care Act and Its ... Accountable Care Organizations and Future Healthcare Delivery ...
... is an ever changing industry. Only ten years ago there ... over traditional shopping. Now we all know that prediction did ... industry has taken another drastic turn. We have entered the ... sites since the success stories for Groupon and LivingSocial fill ...
Cached Medicine Technology:CMR Institute Adds e-Modules Addressing Healthcare Reform's Impact on Pharmaceutical Industry 2Are Daily Deals Next for Medical Industry by PulseOximetersPlus.com 2
(Date:7/7/2015)... ... ... reputable source of authentic tickets for the 2015 CONCACAF Gold Cup Group A matches featuring ... , The 2015 CONCACAF Gold Cup is now upon us as Group A kicks ... will kick off in Frisco, CA from the Toyota Stadium and will feature two exciting ...
(Date:7/7/2015)... ... ... Greatist today announced the acquisition of Blood, Sweat & ... fun activities to do with friends. , The acquisition of BSC strengthens Greatist’s leadership ... events, e-commerce, and brand partnerships. , “I’ve been a huge fan of Blood, Sweat ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... delivery technologies and development solutions for drugs, biologics and consumer health products, ... Inc. to access its antibody combination therapy (ACT) technology platform. The platform ...
(Date:7/7/2015)... , ... July 07, 2015 , ... Healthpointe ... management team. Dr. Alupay, an anesthesiologist and pain management specialist, will be evaluating and ... well as neurological conditions. , After receiving his Bachelor of Science in Biology from ...
(Date:7/7/2015)... ... 07, 2015 , ... Georgia Partnership for TeleHealth ... Georgia, announces the launch of the first ambulance telemedicine program in the state, ... The new program will not only provide more immediate patient care, but will ...
Breaking Medicine News(10 mins):Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 2Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 3Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 3Health News:Georgia Partnership for TeleHealth prepares to Launch First Ambulance Telemedicine Solution in Georgia 2
... MYL ) today announced the appointment of David ... Human Resources (HR), effective,October 22, 2007. Mr. Lillback brings ... joins from Sanofi-Aventis where he served as Vice President,of ... more,than 16,000 employees. Prior to joining Sanofi-Aventis, Mr. Lillback ...
... LAKES, N.J., Oct. 1 BD (Becton,Dickinson and Company) ... conduct a,live webcast of its fourth fiscal quarter 2007 ... a.m. (ET). BD will issue a press,release detailing the ... the conference call will be accessible through BD,s,website at ...
... Crisis Group Offers 10 Tips on Spotting Depression in ... and 20 million,Americans are affected by depression each year, ... gearing up to screen people and educate them,about the ... warning America not to forget a largely overlooked part ...
... Detection ... Oct. 1 To help educate women on how ... Medicine(R),( http://www.USPreventiveMedicine.com ), a company working to organize and,advance ... of screenings to help women with early detection of ...
... 17 ... - 19, 2007 ... and enhances the foundation for success in all,five areas of project ... days, October 17 -,19, is designed to improve implementation, lower rework, ...
... Measures to Recognize Value and Enhance Payments, ... private insurers threaten the future of many of ... ability to continue serving all,patients, concludes a new ... New York State (CHCANYS), and funded by CHCANYS ...
Cached Medicine News:Health News:Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources 2Health News:Children's Experts Warn: Don't Ignore Kids On National Depression Screening Day, October 11 2Health News:Children's Experts Warn: Don't Ignore Kids On National Depression Screening Day, October 11 3Health News:Children's Experts Warn: Don't Ignore Kids On National Depression Screening Day, October 11 4Health News:Children's Experts Warn: Don't Ignore Kids On National Depression Screening Day, October 11 5Health News:Early Breast Cancer Detection Saves Lives 2Health News:Early Breast Cancer Detection Saves Lives 3Health News:Early Breast Cancer Detection Saves Lives 4Health News:Sign Up Now for Project Management Essentials - Three Days of Training in IT Project Management Fundamentals 2Health News:Commercial Insurers' Reimbursement Rate to New York's Community Health Centers Jeopardizes Care 2Health News:Commercial Insurers' Reimbursement Rate to New York's Community Health Centers Jeopardizes Care 3Health News:Commercial Insurers' Reimbursement Rate to New York's Community Health Centers Jeopardizes Care 4
... The design and architectural philosophy of ... elegant and stylish, targeted to a discerning ... take design cues directly from Kenneth Cole ... and jewelry. Contemporary crystal tones in multi-laminations ...
... Eyewear extends that easy, breezy, beautiful image ... featuring an array of stylish colors, trendy ... collection is designed to target the broad ... demands affordability,and high-quality, fashionable frames. The Cover ...
... Flex is a memory metal segment under the ... lightweight, better fitting frame that's comfortable yet durable. ... bend or break won't faze CFX because it ... from classic to modern to sporty and is ...
... Collection is the world's most extensive ... 100% pure titanium and beta-titanium frames ... superior corrosion resistance. This coupled with ... a collection that is a step ...
Medicine Products: